RAB11B and neoplasm: Finally, we were unable to perform adequately powered subgroup analyses to evaluate the impact of adjuvant therapy on the long-term outcomes of specific high-risk populations within the cohort of patients experiencing complete nodal response, such as those with advanced post-therapy tumor staging (ypT3 and ypT4), due to small sample size.